A combination of Sabinsa’s curcumin and piperine (black pepper extract) showed faster symptomatic recovery among COVID-19 patients in India, according to findings from a recent clinical trial.
Sabinsa Corp. has prevailed in yet another patent infringement suit based on its Curcumin C3 Complex ingredient. The most recent settlement is one in a series of suits the company filed to defend its patents in this red-hot sector.